EP1019052A4 - Antagonisten des alpha adrenergischen rezeptors - Google Patents
Antagonisten des alpha adrenergischen rezeptorsInfo
- Publication number
- EP1019052A4 EP1019052A4 EP98931353A EP98931353A EP1019052A4 EP 1019052 A4 EP1019052 A4 EP 1019052A4 EP 98931353 A EP98931353 A EP 98931353A EP 98931353 A EP98931353 A EP 98931353A EP 1019052 A4 EP1019052 A4 EP 1019052A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- alpha
- receptor antagonists
- adrenergic receptor
- adrenergic
- antagonists
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5096097P | 1997-06-18 | 1997-06-18 | |
US50960P | 1997-06-18 | ||
GBGB9800231.4A GB9800231D0 (en) | 1998-01-06 | 1998-01-06 | Alpha 1a adrenergic receptor antagonists |
GB9800231 | 1998-01-06 | ||
PCT/US1998/012672 WO1998057640A1 (en) | 1997-06-18 | 1998-06-18 | Alpha 1a adrenergic receptor antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1019052A1 EP1019052A1 (de) | 2000-07-19 |
EP1019052A4 true EP1019052A4 (de) | 2001-05-16 |
Family
ID=26312903
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP98931353A Withdrawn EP1019052A4 (de) | 1997-06-18 | 1998-06-18 | Antagonisten des alpha adrenergischen rezeptors |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1019052A4 (de) |
JP (1) | JP2002508764A (de) |
AU (1) | AU8150198A (de) |
CA (1) | CA2294346A1 (de) |
WO (1) | WO1998057640A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6207444B1 (en) | 1997-08-05 | 2001-03-27 | Merck & Co., Inc. | Enzymatic process of making alpha 1a adrenergic receptor antagonists using protease |
AU5234899A (en) | 1998-07-30 | 2000-02-21 | Merck & Co., Inc. | Alpha 1a adrenergic receptor antagonists |
US6228870B1 (en) | 1998-11-10 | 2001-05-08 | Merck & Co., Inc. | Oxazolidinones useful as alpha 1a adrenoceptor antagonists |
US6319932B1 (en) | 1998-11-10 | 2001-11-20 | Merck & Co., Inc. | Oxazolidinones useful as alpha 1A adrenoceptor antagonists |
US6358959B1 (en) * | 1999-01-26 | 2002-03-19 | Merck & Co., Inc. | Polyazanaphthalenone derivatives useful as alpha 1a adrenoceptor antagonists |
WO2000063168A1 (en) * | 1999-04-16 | 2000-10-26 | Coelacanth Chemical Corporation | Synthesis of azetidine derivatives |
GB2355456A (en) | 1999-09-30 | 2001-04-25 | Merck & Co Inc | Novel arylhydantoin derivatives useful as alpha 1a adrenoceptor antagonists |
GB2355264A (en) | 1999-09-30 | 2001-04-18 | Merck & Co Inc | Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists |
GB2355457A (en) | 1999-09-30 | 2001-04-25 | Merck & Co Inc | Novel spirotricyclic substituted azacycloalkane derivatives useful as alpha 1a adrenoceptor antagonists |
GB2355263A (en) | 1999-09-30 | 2001-04-18 | Merck & Co Inc | Lactam and cyclic urea derivatives useful as alpha 1a adrenoceptor antagonists |
TWI290549B (en) | 2000-06-02 | 2007-12-01 | Astrazeneca Ab | Process for the preparation of cyclopropyl carboxylic acid ester and derivatives |
WO2007053499A2 (en) | 2005-11-01 | 2007-05-10 | Millennium Pharmaceuticals, Inc. | Compounds useful as antagonists of ccr2 |
US8067457B2 (en) | 2005-11-01 | 2011-11-29 | Millennium Pharmaceuticals, Inc. | Compounds useful as antagonists of CCR2 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9206989D0 (en) * | 1992-03-31 | 1992-05-13 | Glaxo Group Ltd | Chemical compounds |
US5574044A (en) * | 1994-10-27 | 1996-11-12 | Merck & Co., Inc. | Muscarine antagonists |
-
1998
- 1998-06-17 AU AU81501/98A patent/AU8150198A/en not_active Abandoned
- 1998-06-17 CA CA002294346A patent/CA2294346A1/en not_active Abandoned
- 1998-06-18 EP EP98931353A patent/EP1019052A4/de not_active Withdrawn
- 1998-06-18 WO PCT/US1998/012672 patent/WO1998057640A1/en not_active Application Discontinuation
- 1998-06-18 JP JP50478099A patent/JP2002508764A/ja active Pending
Non-Patent Citations (2)
Title |
---|
No further relevant documents disclosed * |
See also references of WO9857640A1 * |
Also Published As
Publication number | Publication date |
---|---|
AU8150198A (en) | 1999-01-04 |
WO1998057640A1 (en) | 1998-12-23 |
JP2002508764A (ja) | 2002-03-19 |
EP1019052A1 (de) | 2000-07-19 |
CA2294346A1 (en) | 1998-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0998285A4 (de) | ANTAGONISTEN DES ALPHA 1a ADRENERISCHEN REZEPTORS | |
EP0822814A4 (de) | ALPHA 1a ADRENERGISCHE REZEPTORANTAGONISTEN | |
SG70110A1 (en) | Ccr-3 receptor antagonists | |
ZA988100B (en) | IL-8 receptor antagonists | |
GB9927227D0 (en) | CCR-3 receptor antagonists III | |
IL131004A0 (en) | Il-8 receptor antagonists | |
GB2343891B (en) | 4-Aroyl-piperidine CCR-3 receptor antagonists | |
EP0833637A4 (de) | Alpha 1a adrenergischer rezeptorantagonist | |
IL130760A0 (en) | Vitronectin receptor antagonists | |
EP1000017A4 (de) | Antagonisten des il-8-rezeptors | |
EP0831823A4 (de) | ALPHA 1a ADRENERGISCHE REZEPTOR-ANTAGONISTEN | |
EP0755392A4 (de) | Alpha1c-adrenergische rezeptorantagonisten | |
IL135028A0 (en) | Vitronectin receptor antagonists | |
EP1019052A4 (de) | Antagonisten des alpha adrenergischen rezeptors | |
EP1023068A4 (de) | ALPHA 1a ADRENOREZEPTOR-ANTAGONISTEN | |
IL131005A0 (en) | Il-8 receptor antagonists | |
EP1014973A4 (de) | ALPHA-1a-ADRENORECEPTOR ANTAGONISTEN | |
HK1028730A1 (en) | Il-8 receptor antagonists | |
EP0971908A4 (de) | Il-8-rezeptor-antagonisten | |
EP0831824A4 (de) | ALPHA 1a ADRENERGISCHE REZEPTORANTAGONISTEN | |
EP0853479A4 (de) | Alpha 1b adrenergischer rezeptorantagonisten | |
AU5234899A (en) | Alpha 1a adrenergic receptor antagonists | |
GB9719392D0 (en) | Alpha la adrenergic receptor antagonists | |
GB9605165D0 (en) | Alpha 1a adrenergic receptor antagonists | |
ZA986969B (en) | Alpha 1a adrenergic receptor antagonist |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20000118 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7A 61K 31/445 A, 7A 61K 31/505 B, 7C 07D 211/18 B, 7C 07D 239/34 B, 7C 07D 491/08 B, 7C 07D 487/04 B, 7C 07D 211/58 B, 7C 07D 413/14 B, 7C 07D 401/04 B, 7C 07D 413/12 B, 7C 07D 401/14 B, 7A 61P 15/10 B |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20010404 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20000703 |